FindTrial
Sign In

TACE+RFA

DEVICE2 trials

Sponsors

Sun Yat-sen University, Jinglong Chen

Conditions

AblationHepatocellular CarcinomaSurgery

Phase 2

Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC
NCT04157140
Jinglong ChenHepatocellular Carcinoma
Start: 2019-11-28End: 2023-03-30Target: 48Updated: 2019-12-03

Phase 3

TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma
NCT01833286
Sun Yat-sen UniversityAblation, Hepatocellular Carcinoma, Surgery
Start: 2013-07-31End: 2019-07-31Target: 200Updated: 2013-04-16

Related Papers

Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.
2025-02-013 citations